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Why should we take interest in studying red blood cells? This mini review attempts
to answer this question and highlights the problems that authors find most appealing
in this dynamic research area. It addresses the early career scientists who are just
starting their independent journey and facing tough times. Despite unlimited access
to information, the exponential development of computational and intellectual powers,
and the seemingly endless possibilities open to talented and ambitious early career
researchers, they soon realize that the pressure of imminent competition for financial
support is hard. They have to hit deadlines, produce data, publish, report, teach,
manage, lead groups, and remain loving family members at the same time. Are these
countless hardships worth it? We think they are. Despite centuries of research, red blood
cells remain a mysterious and fascinating study objects. These cells bring together
experts within the family of the European Red Cell Society and beyond. We all share
our joy for the unknown and excitement in understanding how red cells function and
what they tell us about the microenvironments and macroenvironments they live in. This
review is an invitation to our colleagues to join us on our quest.
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WITH INSPIRATION AND IN MEMORY OF DOUGLAS ADAMS
AND HIS ULTIMATE HITCHHIKER’S GUIDE TO THE GALAXY
(Adams, 1996)
Red blood cells have power over us, no doubt. Making up over 50% of our cells (2 × 1013 cells),
these cells provide us with energy to live, think, and create (Bianconi et al., 2013; Lew and Tiffert,
2017). Each day, we lose 1.7 × 1011 cells and make the same number anew (Lew and Tiffert, 2017).
However, the deeper we delve into the red blood cell universe, the humbler we feel, as we still have
no ultimate answer to “the Question of Life, the Universe, and Everything.”
Are all the 1.7 × 1011 cells we produced today the same? Do they differ from the cells we made
yesterday when we went hiking in the mountains or were swimming in the lake? How do the heat
waves associated with climate change affect these cells? How does microgravity affect them when,
e.g., hitchhiking through the galaxy? How do the cells change as we get older and older with the
increasing life expectancy?
Do the red cells produced today pass away on the same day and from the same cause? For
humans, the causes of death and lifespan of individual cells seem to be somewhat random
(Kaestner and Minetti, 2017), and the investigations to be done are complex, as we cannot trace
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the life cycle of each individual cell back as detectives do. We
do not know exactly what forces red blood cells to die and how
they exactly cease to exist. Some of us acknowledge oxidation-
induced clustering of band 3 proteins in the membrane as a
signal that tags cells with antibodies against these clusters as
“labeled for removal” (Lutz, 2012; Lutz and Bogdanova, 2013).
Others describe red cell death as an “apoptosis-like” process and
call it eryptosis (Lang et al., 2006, 2008). The “Nomenclature
Committee on Cell Death,” specializing in terminology, warns us
for translation of the process as well as the word “eryptosis” to the
way the enucleated cells pass away (Galluzzi et al., 2018). Is there
one or more than one way to die? This question remains unclear
and must still be resolved.
What do we need to learn about red blood cells? As
in Adams’ novels, experts and early career scientists witness
dynamic developments in the field that leave us both excited
and thrilled. We seem to know much about the major
function of red blood cells, which is gas transport, but there
is much more to what these cells are doing. This makes it
difficult to limit the number of ultimate questions to just one
(Figure 1).
There are more than 100 years of evidence for the active
participation of red blood cells in blood coagulation (Duke, 1983;
Andrews and Low, 1999; Steffen et al., 2011; Byrnes andWolberg,
2017). This concept, however, did not mature enough to enter the
textbooks. How many million years will it take?
There are some indications that red blood cells may sense the
changes in plasma levels of hormones, such as insulin (Pedersen
et al., 1982; Zhang et al., 2015), catecholamines (Hasan et al.,
2017) and cortisol (Farese and Plager, 1962), sex hormones
(Koefoed and Brahm, 1994), and erythropoietin (Trial et al., 2001;
Mihov et al., 2009). If so, what happens to the cells as hormones
interact with the receptors on the red blood cell membrane or
cytosolic components?
Red blood cells are famous because they are widely used
as a perfect cell model for studying cell membranes (Agre
and Parker, 1989; Bernhardt and Ellory, 2003; Yawata, 2003).
Earlier, all cells looked the same to the observers, and their
properties were studied “enmasse” e.g. using radioactive isotopes,
rubbing cells between two plates to examine their viscosity and
deformability, by inflating or deflating them, and by applying
all possible approaches to whole blood samples. Mean volume
and hemoglobin content values were assigned to them. Only
desperate experts, such as Marcel Bessis, were photographing red
blood cells for their beauty and turning their appearance into
art by means of scanning electron microscopy (Bessis, 1974).
If we want to study cells of similar densities and, eventually,
ages, we may apply centrifugal force to produce fractions of
such cells (Figure 2). Everyone that has once done such an
experiment appreciates that each red cell has a certain density
and joins one, but not the other group of cells of certain
density, producing a striped pattern in centrifuged samples.
Why certain densities are favored and others avoided is a
question that needs answering. Our current understanding of
red blood cell shapes includes their individual appearance and
properties, their dynamic shape transitions, and their “shape
memory” (Fischer, 2004; Tomaiuolo, 2014; Lanotte et al., 2016;
Cordasco and Bagchi, 2017; Kihm et al., 2018). These studies
make use of cellular and molecular biophysics, sophisticated
in vivo imaging techniques for microfluidic channels and even
blood vessels, and a great deal of artificial intelligence – even
coming close to “Deep Thought,” the supercomputer in Adams’
FIGURE 1 | A schematic of the Red Blood Cell Universe as the authors see it, including a list of ultimate questions.
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FIGURE 2 | Red blood cells may have different densities, as shown on this
continuous Percoll density gradient, but some densities are favored, and
others are mysteriously abandoned.
story – but there is one crucial difference: patients do not have a
million years to wait for the answer.
Most red blood cell researchers are deeply devoted to
developing novel tools that may reveal so far unnoticed sides of
cells we all like to study. Benefits are include protein profiling of
red blood cells using omics approaches (Nemkov et al., 2018).
Technologies use stem cells for production and manipulation
of red blood cells (Hansen et al., 2019). We may follow red
blood cells running through the blood vessels of living hosts
(Hertz et al., 2019; Slovinski et al., 2019) and model and evaluate
responses of red blood cells to mechanical shear forces – the ones
they are exposed to in our microvasculature (Lizarralde Iragorri
et al., 2018; Moura et al., 2019). We can detect electric currents
that ions mediate passing through red blood cell membranes
in hundreds of individual cells at the same time (Rotordam
et al., 2019). As progress in research is fast, sometimes careful
examination of the possible pitfalls and sources of artifacts is
required (Minetti et al., 2013).
There is even more to explore in the universe of
pathophysiology. For some patients, we do not have an
answer as to what causes a red blood cell defect and only know
the symptoms. Even when the molecular cause of the disease
is clear, the links between the defective protein (a mismatch
in amino acid composition or a dysregulated production
program) and disease severity are often unknown. This is the
case for sickle cell disease, hereditary spherocytosis, and Gardos
channelopathy, just to name a few examples. Some patients get
scientists involved into a thrilling quest for the actual cause of
disease, those that were identified by hematologists as carriers
of “idiopathic hemolytic anemia.” New tools are currently in
development that will enable the diagnosis of “newly identified”
diseases (Kaestner and Bianchi, 2020).
Even more mysterious cases are described when defects in
red blood cells come along with neurodegenerative symptoms.
One such disease was named “acanthocytosis” (from the Greek
word “acantha,” meaning “thorn”) because of the spiked thorny
appearance of red blood cells (De Franceschi et al., 2014;
Adjobo-Hermans et al., 2015). In fact, neurons and erythroid
progenitor cells in the bone marrow were recently shown to
share common gene regulatory pathways defining their fate and
properties (Kinney et al., 2019).
The heart and blood also have much in common (Kaestner,
2013). Themortality of patients withmyocardial infarction (acute
coronary syndrome) and those undergoing valve replacement
surgery may be predicted based on the degree of variance in red
blood cell shapes and sizes (Ghaffari et al., 2016; Duchnowski
et al., 2017; Abrahan et al., 2018). Furthermore, red blood cells
were recently shown to function as actors, not passive witnesses,
in cardiovascular diseases, contributing to the regulation of redox
state and vascular tone and activating protective or disruptive
signaling cascades in the myocardium and blood vessels (Pernow
et al., 2019). Can red blood cells be regarded as deputies for other
organs of our body, such as the brain and the heart?
One more exciting and rapidly developing area aims at
revolutionizing blood donations and transfusions. Instead of
relying on people readily offering their blood for the others to
use, researchers are producing, so far in very small amounts, red
blood cells of the type needed for each individual patient in a
test tube (Shah et al., 2014; Hawksworth et al., 2018). However,
it will take some time until cell culture can upscale to provide
enough red blood cells for transfusion. Therefore, before this
happens, we still have to rely on blood donations and do our best
to improve the red blood cell storage conditions (D’Alessandro
and Seghatchian, 2017) and to manage and reduce damage of
cells during lesions (Yoshida et al., 2019). Furthermore, each
patient may decide in the future to use his/her own red blood
cells as transport containers to deliver toxic drugs to the location
in the body where they are supposed to act without poisoning the
host (Villa et al., 2016; Sun et al., 2017). Nature itself has chosen
to modify components of red blood cells to protect hosts from
Plasmodium infection causing a deadly disease that claimed over
400 000 lives in 2018 alone, malaria (Weatherall, 2008; Timmann
et al., 2012; Malaria Genomic Epidemiology et al., 2015). This
evolutionary selection has taken ages to occur and may now be
of use to the development of protective strategies for the human
population, as the spread of Plasmodium further to the north will
follow the increase in atmospheric temperatures.
The universe of red blood cells spreads far beyond the cells
that function inHomo sapiens. In agreement with theHitchhiker’s
Guide, we have learned much about RBCs in the true rulers
of the Earth, mice. These furry fellows give us a chance to
study the mechanisms of diseases and to design new therapies
for mice and humans. Our knowledge of the red blood cells
in other species, including our pets and other tamed and wild,
warm- and cold-blooded creatures that attend veterinary clinics
from time to time, is rather fragmentary and requires more
attention (Figure 1).
The ultimate “Answer to the Ultimate Question of Life, the
Universe, and Everything” may only be given as we keep working
and using our brains along with artificial intelligence. The next
edition of “The Guide to Red Blood Cells” is on the way, and the
motto for the early career scientists in the area stands as stated by
Adams: “Don’t Panic.”
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